FDA's lettuce u-turn

FDA's lettuce u-turn

July 20, 2026 · 4 min

About this episode

The episode discusses the FDA's reversal on lettuce linked to Cyclospora, job cuts at Samsung, and price increases for iPhones in a major market.

The FDA reversed course on lettuce linked to Cyclospora. (00:14) Samsung (SSNLF) is cutting hundreds of U.S. jobs as it shifts operations to Texas. (01:11) Apple (AAPL) just made iPhones more expensive in one of its biggest markets. (02:14) Episode transcripts seekingalpha.com/wsb . Show links: Biggest stock movers Monday: BABA, FRVO, and more Alibaba stock rockets as new Qwen model threatens global rivals, chasing Anthropic’s Fable 5 Ryanair CEO: Unprofitable airlines face a 'difficult winter' amid higher fuel prices SA Asks: Are memory chipmakers building too much capacity? Sign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions .

People in this episode

Host: Seeking Alpha

Topics covered

Mentioned in this episode

Organizations: FDA, Samsung, Apple, Alibaba, Ryanair, Anthropic

Products: iPhones

Places: Texas

More episodes of Wall Street Breakfast

Explore listener stats, chart rankings, contacts and more on the Wall Street Breakfast podcast page.